07 April 2026
Adelaide University researchers are preparing to send living cancer cells into space aboard a suborbital rocket, in a pioneering experiment that could reveal new insights into how cancer develops and survives under extreme conditions.
The project lead researcher Dr Nirmal Robinson from the Centre for Cancer Biology and SAHMRI's Blood Cancer Program will study how cancer cells behave in microgravity – the near-weightless environment experienced in space – during a short research mission lasting about 10-12 minutes.
The initiative is supported by the State Government through the South Australian Space Collaboration and Innovation Fund and is being led in partnership with Cambrian Defence & Space and Blue Dwarf Space.
The rocket will launch from Sweden through an agreement with the Swedish Space Corporation (SSC Space), carrying cancer cells prepared by the Adelaide research team.
Scientists hope the microgravity environment will reveal biological behaviours that are difficult — or impossible — to observe in laboratories on Earth.
“Cancer cells live under enormous stress,” said Dr Robinson.
“Even when chemotherapy kills 99% of tumour cells, there can be a single cell that survives and becomes even more dangerous. If we can understand the mechanisms that allow those cells to adapt, we may be able to develop better ways to target them.”
“When gravity is removed, cells no longer experience sedimentation and many of the mechanical forces present on Earth,” Dr Robinson said.
The experiment will focus on highly adaptable cancer cells, known to play a pivotal role in tumour initiation and progression. These cells can divide indefinitely and generate multiple cell types found within a tumour. Their ability to survive stress, repair tissue and rapidly change their behaviour places them at a critical tipping point where normal cellular function can shift toward cancer development and aggressiveness.
“We want to see how the cells respond to microgravity – whether they multiply more readily, whether they experience different stress responses, or whether certain biological pathways are activated,” Dr Robinson said.
“This project is Australia’s first dedicated microgravity cancer research mission designed to establish a repeatable, sovereign access pathway for biomedical experiments in space,” Dr Robinson said.
The mission is expected to launch later this year.
…………………………………………………………………………………………………………………………
Media contact: Candy Gibson M: +61 434 605 142 E: candy.gibson@unisa.edu.au